ArticleMolecular & cellular oncology2017

Insulin receptor substrate 4 (IRS4) is a constitutive active oncogenic driver collaborating with HER2 and causing therapeutic resistance.

Gerjon J Ikink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.